The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
Authors:
- Michael H. SchwenkMSMichael H. Schwenk
- Paula M. JacobsPJPaula M. Jacobs
- W. Kline BoltonWBW. Kline Bolton
- Mark R. KaplanMKMark R. Kaplan
- Chaim CharytanCCChaim Charytan
- Marilyn GallerMGMarilyn Galler
- 1 October 2005
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 68 (4) , 1801-1807
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah’s Witness patients with severe anemia, iron deficiency and chronic kidney diseaseClinical Nephrology, 2004
- On the relative safety of parenteral iron formulationsNephrology Dialysis Transplantation, 2004
- Blood Pool MR Angiography of Aortic Stent-Graft EndoleakAmerican Journal of Roentgenology, 2004
- Indices of iron status in continuous ambulatory peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 1999
- Intravenous iron for the treatment of predialysis anemiaKidney International, 1999
- Toxicity of parenteral iron dextran therapyKidney International, 1999
- A randomized controlled study of iron supplementation in patients treated with erythropoietinKidney International, 1996
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysisAmerican Journal of Kidney Diseases, 1996
- CLINICAL PROFILESBlood, 1968